Brice Foose

This profile gathers the share dealings of Brice Foose in Invivo Therapeutics Holdings Corp. We count 22 filings; the first trade dates from 5 February 2023 and the latest from 6 February 2023.

Both buying and selling appear: 11 purchases worth €114k, against 11 sales worth €114k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2024: 11 purchases and 11 sales on the market.

In size, the median ticket on the buying side is €11k.

Most recently, on 7 February 2024, the filings show an open-market sale worth €28k in Invivo Therapeutics Holdings Corp. The clock since the last published purchase (7 February 2024) now reads 990 days. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.